Bicycle Therapeutics plcBCYCNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank87
5Y CAGR+9.9%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+9.9%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 24.31% |
| Q2 2025 | -23.36% |
| Q1 2025 | -3.76% |
| Q4 2024 | -5.98% |
| Q3 2024 | -36.87% |
| Q2 2024 | -47.08% |
| Q1 2024 | 41.52% |
| Q4 2023 | -6.77% |
| Q3 2023 | -17.83% |
| Q2 2023 | -3.13% |
| Q1 2023 | -29.78% |
| Q4 2022 | -8.24% |
| Q3 2022 | -9.01% |
| Q2 2022 | 0.30% |
| Q1 2022 | -51.93% |
| Q4 2021 | -26.09% |
| Q3 2021 | 17.27% |
| Q2 2021 | -7.82% |
| Q1 2021 | 6.07% |
| Q4 2020 | -59.81% |
| Q3 2020 | 15.16% |
| Q2 2020 | -8.07% |
| Q1 2020 | -144.40% |
| Q4 2019 | 53.54% |
| Q3 2019 | -28.36% |
| Q2 2019 | -142.50% |
| Q1 2019 | 56.32% |
| Q4 2018 | -18.64% |
| Q3 2018 | -28.22% |
| Q2 2018 | -71.62% |
| Q1 2018 | 52.01% |
| Q4 2017 | 0.00% |